Transcriptomic profiling of scleroderma monocytes reveals links with cardiovascular complications, implicating Notch and interferon pathways
Authors:
- Mehmed T DincMDMehmed T Dinc
- Fatima El-AdiliFEFatima El-Adili
- Justin K LuiJLJustin K Lui
- Subedi KripeshSKSubedi Kripesh
- Michael YorkMYMichael York
- Marcin TrojanowskiMTMarcin Trojanowski
- Giovanni LigrestiGLGiovanni Ligresti
- Robert LafyatisRLRobert Lafyatis
- Maria TrojanowskaMTMaria Trojanowska
- Andreea M BujorABAndreea M Bujor
- 25 July 2025
- journal article
- Published by BMJ in Journal of Scleroderma and Related Disorders
- Vol. 10 (3) , 472-482
Abstract
Objectives: Recent research has highlighted the critical role of monocytes and macrophages in driving both inflammatory and fibrotic processes in systemic sclerosis. This study seeks to elucidate the gene expression profiles of systemic sclerosis monocytes and their potential links to disease complications, with the ultimate goal of uncovering novel therapeutic targets. Methods: A total of 48 systemic sclerosis patients and 15 controls were recruited and monocytes were isolated using CD14+ magnetic beads. Total RNA was extracted and bulk RNA-seq analysis was performed. Differential gene expression followed by unsupervised hierarchical clustering and pathway analysis was conducted, and correlations with clinical features were analyzed. Interferon signature score (IFN6) was calculated using the log transformed values of six genes (IFIT3, IFIT2, MX1, IFIH1, STAT2, and NCF1). Results: We identified four distinct patient subgroups, relative to normal, two with inflammatory and two with non-inflammatory gene profiles. The inflammatory subgroups exhibited high expression of interferon-related genes and included all systemic sclerosis patients with pulmonary hypertension and most with cardiac involvement. In these patients, IFN6 was markedly elevated and showed a significant correlation with global longitudinal strain (GLS; r = −0.5, p = 0.006), a key indicator of cardiac function. Furthermore, pathway analysis identified an enrichment of the Notch signaling pathway among genes whose overexpression correlated with impaired global longitudinal strain. Conclusion: These findings unveil a potential new mechanistic link between interferon activity, Notch signaling, and cardiac complications in systemic sclerosis, offering new insights into disease pathogenesis and potential therapeutic targets.Keywords
Funding Information
- NIH/NHLBI (1R01HL155955-01A1)
- National Institutes of Health (R01HL142596 and R01HL158733)
- CORT grant P50 (P50 AR060780)
- Animal Health Australia (23CDA1052352)
- DOD (SL210018)
- NIH/NIAMS (1P50AR080612-01)
- NIH/NIAMS (1R21AR084251-01)
- the National Scleroderma Foundation
This publication has 49 references indexed in Scilit:
- Interspecies Comparison of Human and Murine Scleroderma Reveals IL-13 and CCL2 as Disease Subset-Specific TargetsThe American Journal of Pathology, 2012
- Altered monocyte and fibrocyte phenotype and function in scleroderma interstitial lung disease: reversal by caveolin-1 scaffolding domain peptideFibrogenesis & Tissue Repair, 2011
- Variants of gene for microsomal prostaglandin E2 synthase show association with disease and severe inflammation in rheumatoid arthritisEuropean Journal of Human Genetics, 2011
- Interferon and alternative activation of monocyte/macrophages in systemic sclerosis-associated pulmonary arterial hypertensionArthritis & Rheumatism, 2011
- Targeting ADAM‐17/notch signaling abrogates the development of systemic sclerosis in a murine modelArthritis & Rheumatism, 2010
- Type I interferon system activation and association with disease manifestations in systemic sclerosisAnnals of the Rheumatic Diseases, 2010
- Molecular Subsets in the Gene Expression Signatures of Scleroderma SkinPLOS ONE, 2008
- A macrophage marker, siglec‐1, is increased on circulating monocytes in patients with systemic sclerosis and induced by type i interferons and toll‐like receptor agonistsArthritis & Rheumatism, 2007
- Scleroderma (systemic sclerosis): classification, subsets and pathogenesis.1988
- Myocardial lesions of progressive systemic sclerosis. A cause of cardiac dysfunction.Circulation, 1976